Search by Drug Name or NDC
NDC 25021-0651-02 Orphenadrine Citrate 30 mg/mL Details
Orphenadrine Citrate 30 mg/mL
Orphenadrine Citrate is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is ORPHENADRINE CITRATE.
Product Information
| NDC | 25021-0651 |
|---|---|
| Product ID | 25021-651_393d82d5-94f5-43fd-b5c8-d0554795233f |
| Associated GPIs | 75100080102005 |
| GCN Sequence Number | 004593 |
| GCN Sequence Number Description | orphenadrine citrate VIAL 30 MG/ML INJECTION |
| HIC3 | H6H |
| HIC3 Description | SKELETAL MUSCLE RELAXANTS |
| GCN | 17653 |
| HICL Sequence Number | 001906 |
| HICL Sequence Number Description | ORPHENADRINE CITRATE |
| Brand/Generic | Generic |
| Proprietary Name | Orphenadrine Citrate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | orphenadrine citrate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 30 |
| Active Ingredient Units | mg/mL |
| Substance Name | ORPHENADRINE CITRATE |
| Labeler Name | Sagent Pharmaceuticals |
| Pharmaceutical Class | Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA090585 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 25021-0651-02 (25021065102)
| NDC Package Code | 25021-651-02 |
|---|---|
| Billing NDC | 25021065102 |
| Package | 10 VIAL in 1 CARTON (25021-651-02) / 2 mL in 1 VIAL |
| Marketing Start Date | 2011-10-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |